Search - tctmd.com

Displaying 81 - 100 of 175

Sort: Relevancy | Date

News Conference News ESC 2019

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

Shelley Wood

August 22, 2019

News Daily News

Genes Bolster Case for Link Between Insomnia and CV Risk

Alison Palkhivala

August 19, 2019

News Conference News EAS 2019

Bempedoic Acid/Ezetimibe Combo Lowers LDL Cholesterol in High-Risk Patients

Michael O'Riordan

May 30, 2019

News Daily News

FDA Tallies Cases of Fournier Gangrene in Patients Taking SGLT2 Inhibitors

Michael O'Riordan

May 08, 2019

News Daily News

Color-Coded Cues and Physician Prompts Boost Evidence-Based Therapy in High-Risk CVD

L.A. McKeown

April 03, 2019

News Conference News ACC 2019

New DECLARE-TIMI 58 Data Shine a Light on Diabetes Patients Most Likely to Benefit From Dapagliflozin

Shelley Wood

March 26, 2019

Presentation ISET 2019

Case-Based Tibial Arterial Disease

Presenter: Alex Powell

January 30, 2019

News Conference News ISET 2019

Chelation for CLI in Diabetic Patients Shows Potential in Small Series

Caitlin E. Cox

January 29, 2019

News Daily News

Dose-Response Benefits for Fiber Intake Seen Across Wide Swath of Acquired Diseases

Shelley Wood

January 15, 2019

News Daily News

SYNTAX Score Should Not Guide Revascularization Strategy in FREEDOM-Like Patients

Michael O'Riordan

December 04, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2018

Shelley Wood

November 30, 2018

News Daily News

Higher Rates of Amputation and Ketoacidosis With SGLT2 Inhibitors: European Registry Data

Michael O'Riordan

November 26, 2018

News Daily News

Obesity Causally Linked to CAD but Not Stroke, Meta-analysis Hints

Caitlin E. Cox

November 21, 2018

News Features

The Price of Knowledge: Industry-Sponsored Studies in the Era of Evidence-Based Medicine

Shelley Wood

October 22, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2018

Shelley Wood

October 02, 2018

News Conference News ESC 2018

Omega-3 Fatty Acids Fail to Reduce CVD Events in Diabetic Patients: ASCEND

Michael O'Riordan

August 26, 2018

News Daily News

In Type 2 Diabetes, Five Risk Factor Targets Keep MI, Stroke, and Death in Check

Caitlin E. Cox

August 15, 2018

News Daily News

‘Doomed’ by Genetics? Lifestyle Still Matters in Preventing CVD and Diabetes

Yael L. Maxwell

June 29, 2018

News Conference News EAS 2018

EAS Consensus Document Examines Safety of Statins Beyond Muscle Symptoms

Yael L. Maxwell

May 11, 2018

News Daily News

Diabetes, Multivessel CAD, and LV Dysfunction? Registry Analysis Gives CABG the Edge Over PCI

Michael O'Riordan

February 20, 2018

Advertisement

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

Genes Bolster Case for Link Between Insomnia and CV Risk

Bempedoic Acid/Ezetimibe Combo Lowers LDL Cholesterol in High-Risk Patients

FDA Tallies Cases of Fournier Gangrene in Patients Taking SGLT2 Inhibitors

Color-Coded Cues and Physician Prompts Boost Evidence-Based Therapy in High-Risk CVD

New DECLARE-TIMI 58 Data Shine a Light on Diabetes Patients Most Likely to Benefit From Dapagliflozin

Case-Based Tibial Arterial Disease

Chelation for CLI in Diabetic Patients Shows Potential in Small Series

Dose-Response Benefits for Fiber Intake Seen Across Wide Swath of Acquired Diseases

SYNTAX Score Should Not Guide Revascularization Strategy in FREEDOM-Like Patients

TCTMD’s Top 10 Most Popular Stories for November 2018

Higher Rates of Amputation and Ketoacidosis With SGLT2 Inhibitors: European Registry Data

Obesity Causally Linked to CAD but Not Stroke, Meta-analysis Hints

The Price of Knowledge: Industry-Sponsored Studies in the Era of Evidence-Based Medicine

TCTMD’s Top 10 Most Popular Stories for September 2018

Omega-3 Fatty Acids Fail to Reduce CVD Events in Diabetic Patients: ASCEND

In Type 2 Diabetes, Five Risk Factor Targets Keep MI, Stroke, and Death in Check

‘Doomed’ by Genetics? Lifestyle Still Matters in Preventing CVD and Diabetes

EAS Consensus Document Examines Safety of Statins Beyond Muscle Symptoms

Diabetes, Multivessel CAD, and LV Dysfunction? Registry Analysis Gives CABG the Edge Over PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content